Effects of sibutramine on the central dopaminergic system in rodents

Neurotoxicity Research

Volumn 3, Issue 3, 2001, Pages 235-247

  Nakagawa, Terutake ^a   Ukai, Kiyoharu ^a   Ohyama, Tadashi ^a   Gomita, Yutaka ^b   Okamura, Hitoshi ^c  

^a KAKEN PHARMACEUTICAL CO LTD   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopamine uptake inhibition; Forced swimming; Methyl 4 phenyl 1, 2, 3, 6 tetrahydro pyridine (MPTP); Reserpine; Rotational behavior

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 3,4 DIHYDROXYPHENYLACETIC ACID; AMFEBUTAMONE; AMITRIPTYLINE; APOMORPHINE; CLOMIPRAMINE; DESIPRAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE UPTAKE INHIBITOR; DOSULEPIN; DRUG METABOLITE; IMIPRAMINE; MAPROTILINE; METHAMPHETAMINE; MIANSERIN; NOMIFENSINE; OXIDOPAMINE; PARGYLINE; PENTOBARBITAL; QUINPIROLE; RESERPINE; SIBUTRAMINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DOPAMINE UPTAKE; DOPAMINERGIC SYSTEM; DRUG EFFECT; FORCED SWIMMING TEST; IMMOBILIZATION; IN VIVO STUDY; MALE; MOLECULAR MIMICRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0034793245     PISSN: 10298428     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03033262     Document Type: Article

References (33)

1. Some central actions of prothiaden, an antidepressant derivative of 6, 11-dyhydrodibenz [b, e] thiepine
2. Is it possible to predict the activity of a new antidepressant in animals with simple psychopharmacological tests?
3. The pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant which induces rapid noradrenergic down-regulation
4. [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: Effect of administration of various antidepressant treatments
5. [3H]nisoxetine--a radioligand for noradrenaline reuptake sites: Correlation with inhibition of [3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments
6. Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat
7. Nomifensine: A potent dopaminergic agonist of antiparkinson potential
8. Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2, 4, 5-trihydroxyphenylalanine (6-hydroxyDOPA)
9. Stereotaxic atlases for the cat, rabbit and rat
10. Expression of dopamine transporter mRNA and its binding site in fetal nigral cells transplanted into the striatum of 6-OHDA lesioned rat
11. [Effects of psychotropic drugs on lateral hypothalamic self-stimulation behavior in rats: Correlation between self-stimulation behavior inhibition and striatal dopaminergic blockade by neuroleptic drugs]
12. A new and highly sensitive method for measuring 3-methoxy-tyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain
13. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: Evidence that dopamine is not a pharmacological target for sibutramine
14. Unexpected differences between mazindol and its homologs on biochemical and behavioral responses
15. Selective action of 6-hydroxydopa on noradrenergic terminals: Mapping of preterminal axons of the brain
16. Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion
17. Does reserpine induce parkinsonian rigidity?
18. The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride
19. Down-regulation of rat cortical a drenoceptors by the putative antidepressant BTS 54 524: Contribution of metabolites
20. Effects of BTS54-524 on some experimental amnesia and brain monoamine
21. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP
22. Effect of cabergoline, a long-acting dopamine D2 agonist, on reserpine- treated rodents
23. Development of a multi-channel automatic measurement system for forced swimming tests and its application for evaluation of psychotropic and nootropic drugs
24. Antidepressive effects of the stereoisomer cis-dosulepin hydrochloride
25. Effects of dopaminergic agents on reversal of reserpine-induced impairment in conditioned avoidance response in rats
26. Effect of sibutramine on extracellar hypothalamus and striatum monoamine levels in rats
27. A comparison of drug-induced rotation in rats lesioned in the medial forebrain bundle with 5, 6-dihydroxytryptamine or 6-hydroxydopamine
28. Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity
29. Antidepressants. A comparative review of the clinical pharmacology and therapeutic use of the 'newer' versus the 'older' drugs
30. Serotonergic conversion of MPTP and dopaminergic accumulation of MPP+
31. Behavioral and biochemical changes following acute administration of MPTP and MPP+
32. Different effects of direct and indirect dopamine receptor agonists on immobility time in reserpine-treated mice